Based on this systematic review and meta-analysis, it was concluded that in G6PDd patients, the side effect of anaemia in single, daily low-dose (0.25 mg/kg/day), and weekly PQ was not statistically and clinically significant, and therefore, a massive screening of G6PD status might not be relevant in all populations. Here, G6PD is linked to anemia (phenotype).